Interleukin-6 is a multifaceted cytokine, usually reported as a pro-inflammatory molecule. However, certain anti-inflammatory activities were also attributed to IL-6. The levels of IL-6 in serum as well as in other biological fluids are elevated in an age-dependent manner. Notably, it is consistently reported also as a key feature of the senescence-associated secretory phenotype. In the elderly, this cytokine participates in the initiation of catabolism resulting in, e.g. sarcopenia. It can cross the blood-brain barrier, and so it is in causal association with, e.g. depression, bipolar disorder, schizophrenia, and anorexia. In the cancer patient, IL-6 is produced by cancer and stromal cells and actively participates in their crosstalk. IL-6 supports tumour growth and metastasising in terminal patients, and it significantly engages in cancer cachexia (including anorexia) and depression associated with malignancy. The pharmacological treatment impairing IL-6 signalling represents a potential mechanism of anti-tumour therapy targeting cancer growth, metastatic spread, metabolic deterioration and terminal cachexia in patients.

Charles University 1st Faculty of Medicine BIOCEV Vestec Czech Republic

Charles University 1st Faculty of Medicine Department of Dermatovenereology Prague Czech Republic

Charles University 1st Faculty of Medicine Institute of Anatomy Prague Czech Republic

Charles University Faculty of Sciences Institute of Cell Biology Vestec Czech Republic

Citace poskytuje Crossref.org

The HOX code of human adult fibroblasts reflects their ectomesenchymal or mesodermal origin

Wound healing: insights into autoimmunity, ageing, and cancer ecosystems through inflammation and IL-6 modulation

Serum concentrations of proinflammatory biomarker interleukin-6 (IL-6) as a predictor of postoperative complications after elective colorectal surgery

The Role of IL-6 in Cancer Cell Invasiveness and Metastasis-Overview and Therapeutic Opportunities

Autoimmunity, cancer and COVID-19 abnormally activate wound healing pathways: critical role of inflammation

Exosomes produced by melanoma cells significantly influence the biological properties of normal and cancer-associated fibroblasts

Cancer-Associated Fibroblasts Influence the Biological Properties of Malignant Tumours via Paracrine Secretion and Exosome Production

Desmoplastic Crosstalk in Pancreatic Ductal Adenocarcinoma Is Reflected by Different Responses of Panc-1, MIAPaCa-2, PaTu-8902, and CAPAN-2 Cell Lines to Cancer-associated/Normal Fibroblasts

IL-6 in the Ecosystem of Head and Neck Cancer: Possible Therapeutic Perspectives

Estrogen Receptor Modulators in Viral Infections Such as SARS-CoV-2: Therapeutic Consequences

Pediatric Inflammatory Multisystem Syndrome (PIMS) - Potential role for cytokines such Is IL-6

Single-Cell RNA Sequencing Unravels Heterogeneity of the Stromal Niche in Cutaneous Melanoma Heterogeneous Spheroids

Interleukin-6: Molecule in the Intersection of Cancer, Ageing and COVID-19

Cutaneous melanoma dissemination is dependent on the malignant cell properties and factors of intercellular crosstalk in the cancer microenvironment (Review)

Role of Interleukin-6 in Lung Complications in Patients With COVID-19: Therapeutic Implications

The Head and Neck Squamous Cell Carcinoma Microenvironment as a Potential Target for Cancer Therapy